| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Legal Officer
1 company
Kearns Evan serves as a Chief Legal Officer at COGT. Across recent SEC filings that breaks down to 0 buys and 1 sell. Those positions are worth an estimated $4.2M at current prices.
The biggest single holding is COGT (~$4.2M) as Chief Legal Officer. The recent filings there lean toward selling, a net 65,000 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 26, 2025 | COGT Cogent Biosciences, Inc. | Chief Legal Officer | Sell | 65,000 | $38.70 | $2,515,500.00 | -37.3% | -5.2% | - |